About
Nanologica AB (publ) is a Swedish biotechnology company based in Sodertalje, specializing in the research and development of pharmaceutical products. The company focuses on developing nanoporous silica-based materials for applications in drug delivery and chromatography, particularly for improving the absorption of poorly water-soluble drugs through nanocarrier technology. Listed on the stock market in 2015, Nanologica operates within the Health Care sector with a niche expertise in pharmaceutical excipients and purification technologies.
Annual results
Reported figures, SEK · revenue up 50.0% in 2025
| Year | Revenue | Net income | Net margin | Free cash flow |
|---|---|---|---|---|
| 2025 | 21.0M | -51.0M | -242.9% | — |
| 2024 | 14.0M | -65.0M | -464.3% | — |
| 2023 | 1.0M | -75.0M | -7500.0% | — |
| 2022 | 1.0M | -55.0M | -5500.0% | — |
| 2021 | 12.0M | -50.0M | -416.7% | — |
NICA.ST in MarketPulse
The live chart with RSI and moving averages, the price, news, signals and price alerts for Nanologica AB (publ) are inside MarketPulse — currently in private beta.
Company data by Eulerpool. Logos provided by Elbstream. Reported figures, not investment advice.